Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combination pharmaceutical agents as inhibitors of HCV replication

Combination pharmaceutical agents as inhibitors of HCV replication

US Patent 9060971 · Granted Jun 23, 2015

Estimated economic value: $8,625,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antiviral heterocyclic compounds2025
Hepatitis B antiviral agents2025
Spiropyrrolidine derived antiviral agents2025
Tetrazole containing apoptosis signal-regulating kinase 1 inhibitors and methods2025
Macrocyclic spiropyrrolidine derived antiviral agents2025
17-beta-hydroxysteroid dehydrogenase type 13 inhibitors and methods of use there2025
Antiviral heterocyclic compounds2025
Benzodiazepine derivatives as RSV inhibitors2025
Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof2025
Combination pharmaceutical agents as RSV inhibitors2025
Functionalized heterocycles as antiviral agents2025
Diagnostic device for remote consultations and telemedicine2024